×
S&P 500   3,882.71 (+0.98%)
DOW   31,248.63 (+0.68%)
QQQ   292.56 (+1.30%)
AAPL   145.60 (+1.88%)
MSFT   268.62 (+0.91%)
META   168.79 (-0.58%)
GOOGL   2,328.33 (+1.61%)
AMZN   114.36 (+0.03%)
TSLA   722.88 (+3.98%)
NVDA   156.18 (+3.23%)
NIO   22.91 (+9.99%)
BABA   124.09 (+4.17%)
AMD   78.35 (+3.98%)
MU   58.53 (+2.02%)
CGC   2.64 (-0.38%)
T   21.10 (+0.05%)
GE   62.30 (+1.19%)
F   11.46 (+3.62%)
DIS   96.46 (+0.40%)
AMC   12.81 (+1.91%)
PFE   53.30 (+1.04%)
PYPL   73.73 (+0.67%)
NFLX   186.27 (+1.20%)
S&P 500   3,882.71 (+0.98%)
DOW   31,248.63 (+0.68%)
QQQ   292.56 (+1.30%)
AAPL   145.60 (+1.88%)
MSFT   268.62 (+0.91%)
META   168.79 (-0.58%)
GOOGL   2,328.33 (+1.61%)
AMZN   114.36 (+0.03%)
TSLA   722.88 (+3.98%)
NVDA   156.18 (+3.23%)
NIO   22.91 (+9.99%)
BABA   124.09 (+4.17%)
AMD   78.35 (+3.98%)
MU   58.53 (+2.02%)
CGC   2.64 (-0.38%)
T   21.10 (+0.05%)
GE   62.30 (+1.19%)
F   11.46 (+3.62%)
DIS   96.46 (+0.40%)
AMC   12.81 (+1.91%)
PFE   53.30 (+1.04%)
PYPL   73.73 (+0.67%)
NFLX   186.27 (+1.20%)
S&P 500   3,882.71 (+0.98%)
DOW   31,248.63 (+0.68%)
QQQ   292.56 (+1.30%)
AAPL   145.60 (+1.88%)
MSFT   268.62 (+0.91%)
META   168.79 (-0.58%)
GOOGL   2,328.33 (+1.61%)
AMZN   114.36 (+0.03%)
TSLA   722.88 (+3.98%)
NVDA   156.18 (+3.23%)
NIO   22.91 (+9.99%)
BABA   124.09 (+4.17%)
AMD   78.35 (+3.98%)
MU   58.53 (+2.02%)
CGC   2.64 (-0.38%)
T   21.10 (+0.05%)
GE   62.30 (+1.19%)
F   11.46 (+3.62%)
DIS   96.46 (+0.40%)
AMC   12.81 (+1.91%)
PFE   53.30 (+1.04%)
PYPL   73.73 (+0.67%)
NFLX   186.27 (+1.20%)
S&P 500   3,882.71 (+0.98%)
DOW   31,248.63 (+0.68%)
QQQ   292.56 (+1.30%)
AAPL   145.60 (+1.88%)
MSFT   268.62 (+0.91%)
META   168.79 (-0.58%)
GOOGL   2,328.33 (+1.61%)
AMZN   114.36 (+0.03%)
TSLA   722.88 (+3.98%)
NVDA   156.18 (+3.23%)
NIO   22.91 (+9.99%)
BABA   124.09 (+4.17%)
AMD   78.35 (+3.98%)
MU   58.53 (+2.02%)
CGC   2.64 (-0.38%)
T   21.10 (+0.05%)
GE   62.30 (+1.19%)
F   11.46 (+3.62%)
DIS   96.46 (+0.40%)
AMC   12.81 (+1.91%)
PFE   53.30 (+1.04%)
PYPL   73.73 (+0.67%)
NFLX   186.27 (+1.20%)

SVB Leerink Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at SVB Leerink. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by SVB Leerink.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
RCKT
Rocket Pharmaceuticals
7/6/2022Target Lowered bySVB LeerinkOutperform$66.00 -> $64.00N/A
BPMC
Blueprint Medicines
7/1/2022Target Lowered bySVB LeerinkAnalyst A. BerensMarket Perform$60.00 -> $56.00Low
TALS
Talaris Therapeutics
6/30/2022Downgraded bySVB LeerinkAnalyst Mani ForooharOutperform -> Market Perform$21.00 -> $7.00Low
UHS
Universal Health Services
6/30/2022Target Lowered bySVB LeerinkMarket Perform$132.00 -> $108.00Low
ROIV
Roivant Sciences
6/29/2022Target Raised bySVB LeerinkOutperform$6.00 -> $7.00Low
AMYT
Amryt Pharma
6/24/2022Reiterated bySVB LeerinkOutperform$18.00 -> $19.00Low
RDUS
Radius Health
6/24/2022Target Raised bySVB LeerinkAnalyst D. RisingerMarket Perform$7.00 -> $10.00Low
FSTX
F-star Therapeutics
6/23/2022Downgraded bySVB LeerinkOutperform -> Market PerformLow
AFMD
Affimed
6/23/2022Target Lowered bySVB LeerinkOutperform$10.00 -> $9.00Low
ACLX
Arcellx
6/23/2022Target Lowered bySVB LeerinkAnalyst D. GrayboschOutperform$47.00 -> $38.00Low
IONS
Ionis Pharmaceuticals
6/21/2022Target Raised bySVB LeerinkMarket Perform$26.00 -> $27.00Low
AMED
Amedisys
6/21/2022Target Lowered bySVB LeerinkMarket Perform$117.00 -> $107.00Low
PRTC
PureTech Health
6/15/2022Target Lowered bySVB LeerinkOutperform$70.00 -> $66.00Low
ALNY
Alnylam Pharmaceuticals
6/15/2022Target Raised bySVB LeerinkMarket Perform$96.00 -> $98.00High
BPMC
Blueprint Medicines
6/13/2022Target Lowered bySVB LeerinkAnalyst A. BerensMarket Perform$82.00 -> $60.00Low
TPTX
Turning Point Therapeutics
6/13/2022Downgraded bySVB LeerinkAnalyst A. BerensOutperform -> Market Perform$101.00 -> $76.00Low
COGT
Cogent Biosciences
6/10/2022Target Raised bySVB LeerinkOutperform$14.00 -> $15.00High
MRNA
Moderna
6/7/2022Target Lowered bySVB LeerinkUnderperform$80.00 -> $70.00Low
HQY
HealthEquity
6/7/2022Target Raised bySVB LeerinkOutperform$67.00 -> $76.00Low
VINC
Vincerx Pharma
6/7/2022Target Lowered bySVB LeerinkOutperform$19.00 -> $6.00High
MRK
Merck & Co., Inc.
6/6/2022Reiterated bySVB LeerinkOutperform $102.00Low
SGEN
Seagen
6/6/2022Target Raised bySVB LeerinkOutperform$155.00 -> $159.00Low
LNTH
Lantheus
6/6/2022Reiterated bySVB LeerinkOutperform $100.00High
SELB
Selecta Biosciences
6/6/2022Initiated bySVB LeerinkAnalyst J. SchwartzOutperform $7.00High
IMUX
Immunic
6/3/2022Target Lowered bySVB LeerinkOutperform$45.00 -> $9.00High
IMTX
Immatics
6/3/2022Target Raised bySVB LeerinkOutperform$25.00 -> $26.00Medium
PHR
Phreesia
6/3/2022Target Lowered bySVB LeerinkAnalyst S. DavisMarket Perform$29.00 -> $22.00High
ELDN
Eledon Pharmaceuticals
6/1/2022Target Lowered bySVB LeerinkOutperform$33.00 -> $26.00High
CHNG
Change Healthcare
5/26/2022Reiterated bySVB LeerinkAnalyst S. DavisOutperformLow
PEPG
PepGen
5/31/2022Initiated bySVB LeerinkAnalyst J. SchwartzOutperform $40.00High
ZYME
Zymeworks
5/27/2022Target Raised bySVB LeerinkAnalyst A. BerensOutperform$18.00 -> $19.00Medium
MRTX
Mirati Therapeutics
5/27/2022Target Lowered bySVB LeerinkAnalyst A. BerensOutperform$164.00 -> $111.00High
AMED
Amedisys
5/27/2022Target Lowered bySVB LeerinkMarket Perform$131.00 -> $117.00Low
FMTX
Forma Therapeutics
5/27/2022Target Lowered bySVB LeerinkOutperform$25.00 -> $23.00High
AVDL
Avadel Pharmaceuticals
5/27/2022Target Lowered bySVB LeerinkOutperform$18.00 -> $6.00High
CRNX
Crinetics Pharmaceuticals
5/26/2022Target Raised bySVB LeerinkOutperform$36.00 -> $39.00Medium
ARGX
argenx
5/24/2022Reiterated bySVB LeerinkAnalyst T. SmithOutperformLow
HLVX
HilleVax
5/24/2022Initiated bySVB LeerinkAnalyst D. RisingerOutperform $30.00High
MIRM
Mirum Pharmaceuticals
5/24/2022Target Raised bySVB LeerinkOutperform$50.00 -> $52.00Low
KDNY
Chinook Therapeutics
5/23/2022Target Raised bySVB LeerinkOutperform$38.00 -> $44.00High
REGN
Regeneron Pharmaceuticals
5/23/2022Initiated bySVB LeerinkOutperform $738.00Medium
SNY
Sanofi
5/23/2022Initiated bySVB LeerinkOutperformMedium
VRTX
Vertex Pharmaceuticals
5/23/2022Initiated bySVB LeerinkMarket Perform $265.00High
TBPH
Theravance Biopharma
5/23/2022Initiated bySVB LeerinkOutperform $12.00High
ROIV
Roivant Sciences
5/23/2022Initiated bySVB LeerinkOutperform $6.00High
RDUS
Radius Health
5/23/2022Initiated bySVB LeerinkMarket Perform $7.00Medium
PFE
Pfizer
5/23/2022Initiated bySVB LeerinkMarket Perform $55.00Low
LLY
Eli Lilly and
5/23/2022Initiated bySVB LeerinkOutperform $341.00Low
HALO
Halozyme Therapeutics
5/23/2022Initiated bySVB LeerinkOutperform $52.00Low
GILD
Gilead Sciences
5/23/2022Initiated bySVB LeerinkMarket Perform $68.00Low
HZNP
Horizon Therapeutics Public
5/23/2022Initiated bySVB LeerinkMarket Perform $95.00High
AMGN
Amgen
5/23/2022Initiated bySVB LeerinkMarket Perform $256.00Low
ABBV
AbbVie
5/23/2022Initiated bySVB LeerinkUnderperform $140.00High
REPL
Replimune Group
5/20/2022Target Lowered bySVB LeerinkOutperform$49.00 -> $48.00High
RCKT
Rocket Pharmaceuticals
5/20/2022Target Raised bySVB LeerinkOutperform$64.00 -> $66.00High
AMTI
Applied Molecular Transport
5/20/2022Target Lowered bySVB LeerinkOutperform$60.00 -> $21.00Low
ENTA
Enanta Pharmaceuticals
5/19/2022Target Lowered bySVB LeerinkMarket Perform$58.00 -> $44.00High
LVTX
LAVA Therapeutics
5/18/2022Target Raised bySVB LeerinkAnalyst D. GrayboschOutperform $25.00Low
SCPH
scPharmaceuticals
5/17/2022Target Raised bySVB LeerinkAnalyst Roanna RuizMarket Perform $6.00Low
HOLX
Hologic
5/17/2022Target Raised bySVB LeerinkOutperform $85.00Low
AGIO
Agios Pharmaceuticals
5/17/2022Target Raised bySVB LeerinkMarket Perform $33.00Medium
RXDX
Prometheus Biosciences
5/12/2022Reiterated bySVB LeerinkAnalyst T. SmithOutperformN/A
CRBU
Caribou Biosciences
5/12/2022Target Raised bySVB Leerink$30.00 -> $34.00High
RPHM
Reneo Pharmaceuticals
5/10/2022Reiterated bySVB LeerinkAnalyst J. SchwartzOutperformHigh
BHVN
Biohaven Pharmaceutical
5/11/2022Downgraded bySVB LeerinkOutperform -> Market Perform $150.00Low
RVMD
Revolution Medicines
5/9/2022Reiterated bySVB LeerinkAnalyst J. ChangOutperformHigh
GDRX
GoodRx
5/10/2022Downgraded bySVB LeerinkAnalyst S. DavisOutperform -> Market Perform$33.00 -> $10.00High
PINC
Premier
5/3/2022Reiterated bySVB LeerinkAnalyst S. DavisOutperformLow
ALGS
Aligos Therapeutics
5/5/2022Downgraded bySVB LeerinkAnalyst R. RuizOutperform -> Market PerformHigh
AMRN
Amarin
5/5/2022Downgraded bySVB LeerinkAnalyst R. RuizOutperform -> Market Perform$10.00 -> $3.00High
LVTX
LAVA Therapeutics
4/27/2022Reiterated bySVB LeerinkAnalyst D. GrayboschOutperformLow
EWTX
Edgewise Therapeutics
4/25/2022Reiterated bySVB LeerinkAnalyst J. SchwartzOutperformHigh
DXCM
DexCom
4/29/2022Target Lowered bySVB Leerink$141.25 -> $125.00High
ACCD
Accolade
4/29/2022Downgraded bySVB LeerinkAnalyst S. DavisOutperform -> Market Perform$32.00 -> $8.00High
SLDB
Solid Biosciences
4/27/2022Reiterated bySVB LeerinkAnalyst J. SchwartzOutperformHigh
TDOC
Teladoc Health
4/28/2022Downgraded bySVB LeerinkAnalyst S. DavisOutperform -> Market PerformHigh
MOLN
Molecular Partners
4/28/2022Target Lowered bySVB Leerink$42.00 -> $29.00Medium
OPT
Opthea
4/26/2022Initiated bySVB LeerinkAnalyst M. GoodmanOutperform $25.00High
MIRM
Mirum Pharmaceuticals
4/26/2022Target Raised bySVB LeerinkOutperform$46.00 -> $49.00Medium
ELYM
Eliem Therapeutics
4/26/2022Target Lowered bySVB LeerinkOutperform$33.00 -> $13.00High
HCA
HCA Healthcare
4/25/2022Target Lowered bySVB LeerinkOutperform$304.00 -> $273.00Medium
THC
Tenet Healthcare
4/22/2022Target Raised bySVB LeerinkAnalyst Whit MayoOutperform$100.00 -> $110.00High
ZLAB
Zai Lab
4/21/2022Target Lowered bySVB LeerinkAnalyst J. ChangOutperform$102.00 -> $101.00High
ALKS
Alkermes
4/21/2022Target Raised bySVB LeerinkMarket Perform$24.00 -> $25.00Low
APTX
Aptinyx
4/21/2022Target Lowered bySVB LeerinkOutperform$10.00 -> $4.00Low
BIIB
Biogen
4/21/2022Target Lowered bySVB LeerinkOutperform$300.00 -> $270.00Medium
ITCI
Intra-Cellular Therapies
4/21/2022Target Raised bySVB LeerinkOutperform$65.00 -> $70.00High
ELV
Elevance Health
4/21/2022Target Raised bySVB LeerinkMarket Perform$483.00 -> $555.00Medium
MRK
Merck & Co., Inc.
4/21/2022Target Lowered bySVB LeerinkOutperform$100.00 -> $97.00Low
UNH
UnitedHealth Group
4/19/2022Target Raised bySVB LeerinkOutperform$550.00 -> $600.00Low
TNDM
Tandem Diabetes Care
4/18/2022Reiterated bySVB LeerinkAnalyst D. AntalffyMarket PerformHigh
NKTR
Nektar Therapeutics
4/18/2022Target Lowered bySVB LeerinkAnalyst Daina GrayboschMarket Perform$7.00 -> $6.00High
THC
Tenet Healthcare
4/14/2022Reiterated bySVB LeerinkAnalyst Whit MayoBuy $100.00N/A
MDT
Medtronic
4/13/2022Reiterated bySVB LeerinkAnalyst D. AntalffyMarket PerformMedium
MYOV
Myovant Sciences
4/13/2022Target Lowered bySVB LeerinkMarket Perform$19.00 -> $12.00High
ZNTL
Zentalis Pharmaceuticals
4/12/2022Target Lowered bySVB LeerinkOutperform$78.00 -> $67.00High
GNFT
Genfit
4/11/2022Target Lowered bySVB LeerinkAnalyst T. SmithOutperform$15.00 -> $10.00High
RUBY
Rubius Therapeutics
4/11/2022Target Lowered bySVB LeerinkMarket Perform$5.00 -> $3.00High
ACHC
Acadia Healthcare
4/8/2022Target Raised bySVB LeerinkOutperform$80.00 -> $90.00High
BLUE
bluebird bio
4/6/2022Target Lowered bySVB LeerinkMarket Perform$10.00 -> $8.00Medium
IMRA
IMARA
4/6/2022Reiterated bySVB LeerinkAnalyst J. SchwartzOutperform -> Market PerformMedium
MRK
Merck & Co., Inc.
4/6/2022Target Lowered bySVB LeerinkAnalyst Daina GrayboschOutperform$101.00 -> $100.00Medium
CALA
Calithera Biosciences
4/4/2022Target Lowered bySVB LeerinkAnalyst J. ChangOutperform$60.00 -> $40.00Medium
ALHC
Alignment Healthcare
4/4/2022Initiated bySVB LeerinkAnalyst W. MayoOutperform $19.00Low
MREO
Mereo BioPharma Group
4/1/2022Reiterated bySVB LeerinkAnalyst Joseph SchwartzBuy $8.00Medium
CNTB
Connect Biopharma
4/1/2022Initiated bySVB LeerinkAnalyst Thomas SmithBuy $22.00High
IONS
Ionis Pharmaceuticals
4/1/2022Target Lowered bySVB LeerinkMarket Perform$29.00 -> $26.00High
SBTX
Silverback Therapeutics
4/1/2022Downgraded bySVB LeerinkAnalyst D. GrayboschOutperform -> Market PerformHigh
PHR
Phreesia
3/31/2022Target Lowered bySVB LeerinkAnalyst S. DavisMarket Perform$41.00 -> $29.00High
AGL
agilon health
3/31/2022Target Raised bySVB LeerinkAnalyst W. MayoOutperform$25.00 -> $33.00High
AXLA
Axcella Health
3/31/2022Target Lowered bySVB LeerinkOutperform$10.00 -> $9.00Medium
PHVS
Pharvaris
3/30/2022Target Lowered bySVB LeerinkOutperform$50.00 -> $45.00Medium
VINC
Vincerx Pharma
3/30/2022Target Lowered bySVB LeerinkAnalyst J. ChangOutperform$24.00 -> $20.00Low
NEO
NeoGenomics
3/29/2022Target Lowered bySVB LeerinkOutperform$45.00 -> $20.00High
ACLX
Arcellx
3/29/2022Target Lowered bySVB LeerinkAnalyst D. GrayboschOutperform$47.00 -> $44.00High
PRVA
Privia Health Group
3/25/2022Target Raised bySVB LeerinkAnalyst W. MayoOutperform$43.00 -> $44.00Low
ETNB
89bio
3/25/2022Target Lowered bySVB LeerinkOutperform$62.00 -> $50.00High
IFRX
InflaRx
3/25/2022Target Lowered bySVB LeerinkOutperform$8.00 -> $6.00Low
MRNA
Moderna
3/25/2022Target Lowered bySVB LeerinkUnderperform$81.00 -> $80.00High
RPHM
Reneo Pharmaceuticals
3/24/2022Target Lowered bySVB LeerinkOutperform$25.00 -> $15.00Low
IMTX
Immatics
3/24/2022Target Lowered bySVB LeerinkOutperform$32.00 -> $25.00Medium
ALGS
Aligos Therapeutics
3/23/2022Target Lowered bySVB LeerinkOutperform$11.00 -> $7.00High
CRBU
Caribou Biosciences
3/22/2022Target Lowered bySVB LeerinkOutperform$32.00 -> $29.00High
GRPH
Graphite Bio
3/22/2022Target Lowered bySVB LeerinkOutperform$34.00 -> $18.00High
MRNS
Marinus Pharmaceuticals
3/22/2022Target Lowered bySVB LeerinkAnalyst M. GoodmanOutperform$30.00 -> $27.00Medium
IPSC
Century Therapeutics
3/18/2022Reiterated bySVB LeerinkAnalyst Daina GrayboschBuy $32.00High
SYBX
Synlogic
3/18/2022Target Lowered bySVB LeerinkOutperform$11.00 -> $8.00High
ATNX
Athenex
3/17/2022Target Raised bySVB LeerinkMarket Perform$2.00 -> $3.00High
BGNE
BeiGene
3/17/2022Downgraded bySVB LeerinkAnalyst A. BerensOutperform -> Market Perform$300.00 -> $177.00Low
IMRA
IMARA
3/16/2022Target Lowered bySVB LeerinkAnalyst J. SchwartzOutperform$37.00 -> $31.00High
SPRB
Spruce Biosciences
3/16/2022Target Lowered bySVB LeerinkAnalyst J. SchwartzMarket Perform$5.00 -> $3.00High
ELV
Elevance Health
3/15/2022Target Raised bySVB LeerinkAnalyst W. MayoMarket Perform$465.00 -> $483.00Medium
AGL
agilon health
3/15/2022Target Lowered bySVB LeerinkAnalyst W. MayoOutperform$35.00 -> $25.00High
ADAP
Adaptimmune Therapeutics
3/15/2022Target Lowered bySVB LeerinkMarket Perform$7.00 -> $3.00High
ASND
Ascendis Pharma A/S
3/15/2022Target Raised bySVB LeerinkOutperform$190.00 -> $193.00High
NKTR
Nektar Therapeutics
3/15/2022Target Lowered bySVB LeerinkMarket Perform$18.00 -> $7.00High
PRDS
Pardes Biosciences
3/15/2022Initiated bySVB LeerinkAnalyst R. RuizOutperform $18.00Low
VEEV
Veeva Systems
3/14/2022Reiterated bySVB LeerinkAnalyst Stephanie DavisBuy $268.00Low
AIRS
AirSculpt Technologies
3/14/2022Target Raised bySVB LeerinkAnalyst W. MayoOutperform$26.00 -> $27.00High
HARP
Harpoon Therapeutics
3/11/2022Target Lowered bySVB Leerink$19.00 -> $13.00High
ALGS
Aligos Therapeutics
3/11/2022Target Raised bySVB LeerinkAnalyst R. RuizOutperform$10.00 -> $11.00High
NPCE
NeuroPace
3/11/2022Target Lowered bySVB LeerinkOutperform$15.00 -> $12.00High
RXDX
Prometheus Biosciences
3/10/2022Target Raised bySVB LeerinkOutperform$47.00 -> $55.00Medium
AMYT
Amryt Pharma
3/10/2022Target Raised bySVB LeerinkOutperform$9.00 -> $10.00High
PRCT
PROCEPT BioRobotics
3/9/2022Target Raised bySVB LeerinkAnalyst D. AntalffyOutperform$25.00 -> $30.00High
MASS
908 Devices
3/8/2022Target Lowered bySVB LeerinkOutperform$40.00 -> $30.00High
AUPH
Aurinia Pharmaceuticals
3/8/2022Target Lowered bySVB LeerinkOutperform$30.00 -> $22.00High
BLUE
bluebird bio
3/7/2022Target Lowered bySVB LeerinkMarket Perform$11.00 -> $10.00Low
RXRX
Recursion Pharmaceuticals
3/4/2022Downgraded bySVB LeerinkAnalyst M. ForooharOutperform -> Market Perform$32.00 -> $10.00High
BBIO
BridgeBio Pharma
3/4/2022Target Raised bySVB LeerinkAnalyst M. ForooharOutperform$24.00 -> $25.00Medium
VEEV
Veeva Systems
3/3/2022Target Lowered bySVB LeerinkAnalyst S. DavisOutperform$282.00 -> $268.00High
GMTX
Gemini Therapeutics
3/3/2022Downgraded bySVB LeerinkAnalyst Marc GoodmanOutperform -> Market Perform$10.00 -> $2.00High
MDRX
Allscripts Healthcare Solutions
3/3/2022Target Raised bySVB LeerinkAnalyst S. DavisOutperform$22.00 -> $24.00Medium
ICPT
Intercept Pharmaceuticals
3/3/2022Target Lowered bySVB LeerinkMarket Perform$30.00 -> $27.00Medium
CPSI
Computer Programs and Systems
3/3/2022Target Raised bySVB LeerinkOutperform$35.00 -> $38.00High
ZLAB
Zai Lab
3/2/2022Target Lowered bySVB LeerinkAnalyst J. ChangOutperform$194.00 -> $102.00High
KPTI
Karyopharm Therapeutics
3/2/2022Target Lowered bySVB LeerinkMarket Perform$8.00 -> $6.00High
SGRY
Surgery Partners
3/2/2022Target Raised bySVB LeerinkAnalyst W. MayoOutperform$63.00 -> $65.00High
RGNX
REGENXBIO
3/2/2022Target Lowered bySVB LeerinkMarket Perform$29.00 -> $25.00Medium
QTRX
Quanterix
3/2/2022Target Lowered bySVB LeerinkOutperform$70.00 -> $50.00Medium
OSH
Oak Street Health
3/2/2022Target Raised bySVB LeerinkAnalyst W. MayoMarket Perform$17.00 -> $23.00Low
ITCI
Intra-Cellular Therapies
3/2/2022Target Raised bySVB LeerinkOutperform$50.00 -> $65.00Low
HCAT
Health Catalyst
3/2/2022Target Lowered bySVB LeerinkAnalyst S. DavisOutperform$64.00 -> $48.00High
AXSM
Axsome Therapeutics
3/2/2022Target Lowered bySVB LeerinkOutperform$65.00 -> $50.00Low
AHCO
AdaptHealth
3/2/2022Target Lowered bySVB LeerinkAnalyst W. MayoOutperform$32.00 -> $24.00High
ACHC
Acadia Healthcare
3/1/2022Target Lowered bySVB LeerinkAnalyst W. MayoOutperform$83.00 -> $80.00High
GDRX
GoodRx
3/1/2022Target Lowered bySVB LeerinkAnalyst S. DavisOutperform$49.00 -> $33.00High
ACLX
Arcellx
3/1/2022Initiated bySVB LeerinkAnalyst D. GrayboschOutperform $47.00High
VCYT
Veracyte
3/1/2022Target Lowered bySVB LeerinkOutperform$45.00 -> $40.00Medium
AVIR
Atea Pharmaceuticals
3/1/2022Target Lowered bySVB LeerinkAnalyst R. RuizMarket Perform$10.00 -> $9.00High
UHS
Universal Health Services
2/28/2022Target Raised bySVB LeerinkAnalyst W. MayoMarket Perform$136.00 -> $139.00Low
TRHC
Tabula Rasa HealthCare
2/28/2022Target Lowered bySVB LeerinkMarket Perform$23.00 -> $11.00High
BGNE
BeiGene
2/28/2022Target Lowered bySVB LeerinkOutperform$334.00 -> $300.00Medium
AXNX
Axonics
2/25/2022Target Raised bySVB LeerinkOutperform$60.00 -> $65.00High
RUBY
Rubius Therapeutics
2/25/2022Target Lowered bySVB LeerinkMarket Perform$14.00 -> $5.00High
ABCL
AbCellera Biologics
2/25/2022Target Lowered bySVB LeerinkOutperform$25.00 -> $20.00High
VCEL
Vericel
2/25/2022Target Raised bySVB LeerinkOutperform$40.00 -> $45.00Medium
SAGE
Sage Therapeutics
2/25/2022Target Lowered bySVB LeerinkAnalyst M. GoodmanMarket Perform$60.00 -> $50.00High
NVTA
Invitae
2/25/2022Target Lowered bySVB LeerinkOutperform$30.00 -> $25.00High
MRNA
Moderna
2/25/2022Target Lowered bySVB LeerinkUnderperform$85.00 -> $81.00Medium
MGNX
MacroGenics
2/25/2022Target Lowered bySVB LeerinkOutperform$40.00 -> $23.00High
KURA
Kura Oncology
2/25/2022Target Lowered bySVB LeerinkOutperform$41.00 -> $28.00High
IONS
Ionis Pharmaceuticals
2/25/2022Target Lowered bySVB LeerinkMarket Perform$34.00 -> $29.00Medium
EDIT
Editas Medicine
2/25/2022Target Lowered bySVB LeerinkAnalyst R. BienkowskiMarket Perform$41.00 -> $27.00High
CYRX
Cryoport
2/25/2022Target Raised bySVB LeerinkOutperform$75.00 -> $92.00High
CLOV
Clover Health Investments
2/25/2022Target Lowered bySVB LeerinkAnalyst W. MayoMarket Perform$3.00 -> $2.50High
FOLD
Amicus Therapeutics
2/24/2022Target Lowered bySVB LeerinkAnalyst J. SchwartzOutperform$16.00 -> $14.00High
LNTH
Lantheus
2/24/2022Target Raised bySVB LeerinkAnalyst D. AntalffyOutperform$34.00 -> $75.00High
RCKT
Rocket Pharmaceuticals
2/24/2022Target Raised bySVB LeerinkOutperform$62.00 -> $64.00High
AZN
AstraZeneca
2/24/2022Target Raised bySVB LeerinkOutperform$65.00 -> $70.00Low
NARI
Inari Medical
2/24/2022Target Raised bySVB LeerinkOutperform$85.00 -> $95.00High
NVRO
Nevro
2/24/2022Target Lowered bySVB LeerinkAnalyst Danielle AntalffyOutperform$105.00 -> $85.00High
ONEM
1Life Healthcare
2/24/2022Target Lowered bySVB LeerinkAnalyst W. MayoMarket Perform$24.00 -> $10.00High
GH
Guardant Health
2/24/2022Target Lowered bySVB LeerinkOutperform$170.00 -> $140.00High
TNDM
Tandem Diabetes Care
2/23/2022Target Lowered bySVB LeerinkAnalyst Danielle AntalffyMarket Perform$140.00 -> $120.00High
TDOC
Teladoc Health
2/23/2022Target Lowered bySVB LeerinkOutperform$193.00 -> $161.00High
EXAS
Exact Sciences
2/23/2022Target Lowered bySVB LeerinkOutperform$140.00 -> $130.00High
A
Agilent Technologies
2/23/2022Target Lowered bySVB LeerinkOutperform$175.00 -> $145.00High
AGIO
Agios Pharmaceuticals
2/22/2022Target Lowered bySVB LeerinkMarket Perform$32.00 -> $30.00Low
IMGN
ImmunoGen
2/22/2022Target Lowered bySVB LeerinkMarket Perform$7.00 -> $5.00Low
OSH
Oak Street Health
2/22/2022Target Lowered bySVB LeerinkAnalyst W. MayoMarket Perform$41.00 -> $17.00Medium
INSM
Insmed
2/22/2022Target Lowered bySVB LeerinkOutperform$57.00 -> $52.00Low
CI
Cigna
2/22/2022Target Raised bySVB LeerinkAnalyst Jim KellyMarket Perform$224.00 -> $245.00Medium
MREO
Mereo BioPharma Group
2/17/2022Reiterated bySVB LeerinkAnalyst J. SchwartzOutperformN/A
SWAV
ShockWave Medical
2/18/2022Target Raised bySVB LeerinkOutperform$160.00 -> $190.00High
ARVN
Arvinas
2/18/2022Target Lowered bySVB LeerinkAnalyst C. LiuOutperform$97.00 -> $91.00Low
RGEN
Repligen
2/18/2022Target Lowered bySVB LeerinkOutperform$275.00 -> $250.00Low
MRSN
Mersana Therapeutics
2/18/2022Target Lowered bySVB LeerinkOutperform$25.00 -> $16.00High
AMED
Amedisys
2/18/2022Target Raised bySVB LeerinkAnalyst W. MayoMarket Perform$145.00 -> $147.00Low
AHCO
AdaptHealth
2/18/2022Target Lowered bySVB LeerinkAnalyst W. MayoOutperform$35.00 -> $32.00High
BPMC
Blueprint Medicines
2/17/2022Target Lowered bySVB LeerinkAnalyst A. BerensOutperform -> Market Perform$93.00 -> $82.00High
GMAB
Genmab A/S
2/17/2022Target Lowered bySVB LeerinkMarket Perform$42.00 -> $39.00High
XERS
Xeris Biopharma
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizOutperform$8.00 -> $6.00Medium
MYOV
Myovant Sciences
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizMarket Perform$21.00 -> $19.00Low
HOOK
Hookipa Pharma
2/16/2022Target Raised bySVB LeerinkAnalyst A. BerensOutperform$3.00 -> $4.00High
CRSP
CRISPR Therapeutics
2/16/2022Target Lowered bySVB LeerinkAnalyst R. BienkowskiOutperform$126.00 -> $120.00Medium
CPSI
Computer Programs and Systems
2/16/2022Target Lowered bySVB LeerinkOutperform$37.00 -> $35.00High
CFRX
ContraFect
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizOutperform$14.00 -> $9.00High
AVIR
Atea Pharmaceuticals
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizMarket Perform$11.00 -> $10.00Low
AMRN
Amarin
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizOutperform$11.00 -> $10.00Medium
ALLK
Allakos
2/16/2022Target Lowered bySVB LeerinkAnalyst T. SmithMarket Perform$17.00 -> $13.00High
ALGS
Aligos Therapeutics
2/16/2022Target Lowered bySVB LeerinkAnalyst R. RuizOutperform$15.00 -> $10.00Medium
BRKR
Bruker
2/14/2022Target Raised bySVB LeerinkOutperform$84.00 -> $85.00Medium
ILMN
Illumina
2/11/2022Target Lowered bySVB LeerinkAnalyst P. SoudaMarket Perform$430.00 -> $400.00High
ALNY
Alnylam Pharmaceuticals
2/11/2022Target Lowered bySVB LeerinkAnalyst M. ForooharMarket Perform$109.00 -> $103.00Medium
ALVR
AlloVir
2/10/2022Target Lowered bySVB LeerinkOutperform$32.00 -> $30.00High
SGEN
Seagen
2/10/2022Target Lowered bySVB LeerinkOutperform$179.00 -> $155.00High
TSVT
2seventy bio
2/10/2022Initiated bySVB LeerinkAnalyst D. GrayboschOutperform $38.00High
RGNX
REGENXBIO
2/10/2022Target Lowered bySVB LeerinkMarket Perform$35.00 -> $29.00High
THC
Tenet Healthcare
2/9/2022Upgraded bySVB LeerinkAnalyst W. MayoMarket Perform -> Outperform$88.00 -> $100.00High
ENTA
Enanta Pharmaceuticals
2/9/2022Target Lowered bySVB LeerinkAnalyst R. RuizMarket Perform$80.00 -> $68.00High
INCY
Incyte
2/9/2022Downgraded bySVB LeerinkMarket Perform -> Underperform$60.00 -> $56.00Low
TPTX
Turning Point Therapeutics
2/8/2022Reiterated bySVB LeerinkAnalyst A. BerensOutperformHigh
MRTX
Mirati Therapeutics
2/8/2022Reiterated bySVB LeerinkAnalyst A. BerensOutperformHigh
HOOK
Hookipa Pharma
2/8/2022Reiterated bySVB LeerinkAnalyst A. BerensOutperformHigh
CGEM
Cullinan Oncology
2/8/2022Reiterated bySVB LeerinkAnalyst A. BerensOutperformHigh
INSP
Inspire Medical Systems
2/9/2022Target Raised bySVB LeerinkAnalyst D. AntalffyOutperform$270.00 -> $273.00High
ZBH
Zimmer Biomet
2/8/2022Target Lowered bySVB LeerinkAnalyst D. AntalffyOutperform$150.00 -> $135.00High
MRK
Merck & Co., Inc.
2/4/2022Target Lowered bySVB LeerinkAnalyst Daina GrayboschOutperform$102.00 -> $101.00Medium
TWST
Twist Bioscience
2/7/2022Target Lowered bySVB LeerinkMarket Perform$110.00 -> $70.00High
CSII
Cardiovascular Systems
2/4/2022Target Lowered bySVB LeerinkOutperform$25.00 -> $20.00High
BDX
Becton, Dickinson and
2/4/2022Target Raised bySVB LeerinkAnalyst D. AntalffyMarket Perform$270.00 -> $275.00Low
ABMD
Abiomed
2/4/2022Target Lowered bySVB LeerinkMarket Perform$345.00 -> $325.00Low
HUM
Humana
2/3/2022Target Lowered bySVB LeerinkAnalyst Jim KellyOutperform$528.00 -> $525.00Medium
BSX
Boston Scientific
2/3/2022Target Lowered bySVB LeerinkMarket Perform$48.00 -> $45.00High
ARWR
Arrowhead Pharmaceuticals
2/3/2022Target Lowered bySVB LeerinkMarket Perform$46.00 -> $36.00Low
WAT
Waters
2/2/2022Target Lowered bySVB LeerinkMarket Perform$375.00 -> $350.00High
TECH
Bio-Techne
2/2/2022Target Raised bySVB LeerinkOutperform$530.00 -> $575.00High
SIOX
Sio Gene Therapies
2/1/2022Downgraded bySVB LeerinkAnalyst M. ForooharOutperform -> Market Perform$6.00 -> $1.00High
AMLX
Amylyx Pharmaceuticals
2/1/2022Reiterated bySVB LeerinkAnalyst M. GoodmanOutperform $50.00High

MarketBeat Community Rating for SVB Leerink

Community Ranking:  2.8 out of 5 (
2.8 of 5 stars)
Outperform Votes:  17,755 (Vote Outperform)
Underperform Votes:  14,143 (Vote Underperform)
Total Votes:  31,898
MarketBeat's community ratings are surveys of what our community members think about SVB Leerink and other research firms. Vote "Outperform" if you believe SVB Leerink's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVB Leerink's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.